Celldex Therapeutics (CLDX) Tax Rate (2017 - 2021)

Celldex Therapeutics (CLDX) posted quarterly Tax Rate of 1.1% for Q3 2021, up 127.86% quarter-over-quarter from 3.94% in Q4 2020.

Celldex Therapeutics (CLDX) Tax Rate (2017 - 2021) Analysis & Trends

Celldex Therapeutics' Tax Rate history runs 4 years deep, the most recent figure standing at 1.1% for Q3 2021.

In Q3 2021, Tax Rate changed N/A year-over-year to 1.1%; the TTM figure through Dec 2021 stood at 0.95% (down 902.0% YoY), while the FY2023 annual figure was 21.0%, changed 0.0% from the prior year.
Tax Rate for Q3 2021 stood at 1.1%, up from 3.94% in the prior quarter.
The five-year high for Tax Rate was 83.24% in Q4 2017, with the low at 3.94% in Q4 2020.
The 4-year median for Tax Rate is 1.44% (2020), against an average of 19.89%.
Peak annual rise in Tax Rate reached 2325 bps in 2018, while the deepest fall reached 2325 bps in 2018.
Celldex Therapeutics' Tax Rate stood at 83.24% in 2017, then dropped by 28 bps to 59.99% in 2018, then plunged by 107 bps to 3.94% in 2020, then jumped by 128 bps to 1.1% in 2021.
Business Quant data shows CLDX's Tax Rate at 1.1% in Q3 2021, 3.94% in Q4 2020, and 1.78% in Q2 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Tax Rate (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	20.98%
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	15.11%
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	10.91%
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	24.15%
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-9.47%
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	7.49%
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	-16.71%
10	Celldex Therapeutics	3.29 Bn	2.58 Bn	-2.57 Mn	-

Download Data